全文获取类型
收费全文 | 23779篇 |
免费 | 1785篇 |
国内免费 | 107篇 |
专业分类
耳鼻咽喉 | 237篇 |
儿科学 | 758篇 |
妇产科学 | 580篇 |
基础医学 | 3177篇 |
口腔科学 | 360篇 |
临床医学 | 2441篇 |
内科学 | 5135篇 |
皮肤病学 | 653篇 |
神经病学 | 2252篇 |
特种医学 | 653篇 |
外科学 | 3017篇 |
综合类 | 493篇 |
一般理论 | 19篇 |
预防医学 | 1861篇 |
眼科学 | 490篇 |
药学 | 1668篇 |
中国医学 | 30篇 |
肿瘤学 | 1847篇 |
出版年
2021年 | 387篇 |
2020年 | 206篇 |
2019年 | 330篇 |
2018年 | 405篇 |
2017年 | 311篇 |
2016年 | 366篇 |
2015年 | 408篇 |
2014年 | 550篇 |
2013年 | 810篇 |
2012年 | 1130篇 |
2011年 | 1217篇 |
2010年 | 601篇 |
2009年 | 662篇 |
2008年 | 1129篇 |
2007年 | 1188篇 |
2006年 | 1111篇 |
2005年 | 1152篇 |
2004年 | 1088篇 |
2003年 | 982篇 |
2002年 | 993篇 |
2001年 | 695篇 |
2000年 | 691篇 |
1999年 | 589篇 |
1998年 | 260篇 |
1997年 | 231篇 |
1996年 | 176篇 |
1995年 | 186篇 |
1994年 | 181篇 |
1993年 | 161篇 |
1992年 | 496篇 |
1991年 | 496篇 |
1990年 | 475篇 |
1989年 | 479篇 |
1988年 | 382篇 |
1987年 | 406篇 |
1986年 | 415篇 |
1985年 | 376篇 |
1984年 | 285篇 |
1983年 | 300篇 |
1982年 | 191篇 |
1980年 | 144篇 |
1979年 | 249篇 |
1978年 | 186篇 |
1977年 | 167篇 |
1976年 | 180篇 |
1975年 | 195篇 |
1974年 | 182篇 |
1973年 | 167篇 |
1971年 | 146篇 |
1970年 | 149篇 |
排序方式: 共有10000条查询结果,搜索用时 234 毫秒
1.
2.
3.
4.
5.
6.
7.
Abraham Manoj-Thomas A Gadgil 《European journal of orthopaedic surgery & traumatology : orthopedie traumatologie》2006,16(2):178-180
Nutcracker fracture of the cuboid is a rare injury usually caused by forced abduction of the forefoot on a fixed hindfoot. We report a case of this fracture in a 58-year-old man who was treated on the principle of ligamentotaxis and the position being held with Kirchner wires for a period of 5 weeks. He recovered without any complications and with good ankle and subtalar movements. At 5 months following the injury he had returned to his previous occupation. We think this novel way of treating this rare fracture is simple and gave a good result in this patient. 相似文献
8.
Mark S. Wallace Steven G. Charapata Robert Fisher Michael Byas‐Smith Peter S. Staats Martha Mayo Dawn McGuire David Ellis 《Neuromodulation》2006,9(2):75-86
Objective. The safety and efficacy of intrathecal (IT) ziconotide was studied in a randomized, double‐blind, placebo‐controlled trial. Materials and Methods. Patients (169 ziconotide, 86 placebo) with severe chronic nonmalignant pain unresponsive to conventional therapy and a visual analog scale of pain intensity (VASPI score) ≥ 50 mm were treated over a 6‐day period in an inpatient hospital setting. Initial starting dose was 0.4 µg/hour and was titrated to analgesia or intolerance (maximum dose 7.0 µg/hour). The starting and maximum doses were reduced to 0.1 µg/hour and 2.4 µg/hour, respectively, due to adverse events (AEs). Results. The mean percent reduction in VASPI score from baseline was 31.2% and 6.0% for ziconotide‐ and placebo‐treated patients, respectively (p ≤ 0.001). During the initial titration phase, a significantly greater percentage of patients in the ziconotide group compared to the placebo group reported AEs, including abnormal gait, amblyopia, dizziness, nausea, nystagmus, pain, urinary retention, and vomiting. Conclusion. Ziconotide provided significant analgesia in patients for whom conventional therapy failed. However, there was a considerable incidence of ziconotide‐associated AEs due to the rapid titration and high doses administered. 相似文献
9.
Regina Gershkovich David Sacks Abraham Chlibovsky Sonia Yudaev Asher Korzets 《Nephrology, dialysis, transplantation》2006,21(2):539-540
Case report A 28-year-old female patient was admitted because of painlessmacroscopic haematuria. Past history included severe mentalretardation and nystagmus. At age 17, a computed tomography(CT) scan of the brain showed an absent cerebellar vermis andcerebellar hypoplasia. There was no 相似文献
10.
Abraham Nudelman Yitschak Binnes Naomi Shmueli-Broide Yael Odessa J. Paul Hieble Anthony C. Sulpizio 《Archiv der Pharmazie》1996,329(3):125-132
Vinylogous (Groups III and V ) and acetylenologous (Group IV ) analogs of the classical β-adrenergic agents — stimulants and blockers — were prepared in order to evaluate the effect of degree of saturation, position of unsaturation and rigidity of the chain linking the aromatic ring and the amino containing functional group on biological activity. Derivatives from Group III , which represent 4-aryl-3-butenyl-2-ol-amine analogs of Group II , retained β1-adrenoceptor antagonist activity albeit substantially less potent (50–200-fold) than that possessed by their aryloxy counterparts. Consistent with the SAR for Group II compounds, substitution at position 2 of the aromatic ring yielded the most potent antagonists ( 5a, 5d, 5g ), with KB's ranging from 73–93 nM while 3,4-dichloro substitution ( 5e ) markedly reduced antagonist potency (KB = 2,400 nM). Agonist activity was also noted for 5b and 5d , suggesting that these compounds may be best classified as partial agonists. Representatives from Groups IV and V were inactive as antagonists at the β1-adrenoceptor confirming the importance of the spatial relationship between the hydroxyl and the amino nitrogen. 相似文献